|Other Titles||Efficacy and safety of tacrolimus ointment for facial sensitive skin in adults|
|Abstract||目的：观察0.1%的他克莫司软膏治疗成年人面部敏感性皮肤的疗效和安全性。方法给予36例诊断为敏感性皮肤的患者外用0.1%他克莫司软膏，每日2次，共3周，如果用药不到3周痊愈，可停止用药。于治疗前及治疗后1、3周和停药后4周各随访1次，评估病情严重程度及临床疗效。采用皮肤病生活质量调查问卷评估敏感性皮肤对生活质量的影响。结果36例患者中32例完成临床试验。治疗3周后皮炎症状的临床痊愈率、显效率分别为46.9%、40.6%，有效率为87.5%。治疗3周后10项评估指标及生活质量均有明显改善（P ＜0.001）。主观症状改善最明显的是自觉干燥、针刺感。客观症状中脱屑、干燥症状对治疗的反应最好。药物不良反应发生率为72.2%（瘙痒占30.8%，烧灼感占69.2%，刺痛占7.7%），其中有50%只出现于用药后2d 内。结论0.1%他克莫司软膏治疗成年人面部敏感性皮肤安全、有效，刺激反应较普遍，多为一过性，可耐受。|
Objective To investigate the clinical efficacy and safety of topical 0.1% tacrolimus ointment in the treatment of adults patient with facial sensitive skin. Methods Total 36 cases were treated with topical 0.1% tacrolimus ointment, twice daily, and the clinical symptom and sign scores were recorded before and after the treatment. A new scale, which including 6 subjective skin conditions (pricking, burning sensation, itching, pain, dry sensation, tightness) and 4 visible skin conditions (erythema, swelling, scaling, dryness) was adopted for assessment at the baseline and succeeding improvement of skin condition. Dermatology life quality index was used to evaluate the impact of sensitive skin on life quality. Meanwhile the adverse events were observed. Results Thirty-two of the 36 cases completed the whole course of treatment. The cure rate was 46.9%(15/32), markedly improvement rate was 40.6%(13/32), moderate improvement rate was 12.5%(4/32), all cases were effective. The most obviously improved conditions were dry sensation, pricking, dryness and scaling. Adverse events caused by local irritation such as burning, sting and pruritus, were common (totally 72.2%), but most of these adverse events were transient and tolerable. Conclusion 0.1% tacrolimus ointment may be a safe and effective treatment option for the adults with facial sensitive skin.
|Appears in Collections:||第三医院|